Perrigo (PRGO) Other Operating Expenses (2012 - 2026)
Perrigo (PRGO) posted quarterly Other Operating Expenses of $483.1 million for Q1 2026, up 738.72% year-over-year from $57.6 million in Q1 2025, and down 67.75% quarter-over-quarter from $1.5 billion in Q4 2025.
Perrigo (PRGO) Other Operating Expenses (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Other Operating Expenses for 14 consecutive years, with $483.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 738.72% year-over-year to $483.1 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 6659.45% YoY), while the FY2025 annual figure was $2.0 billion, up 33658.33% from the prior year.
- Other Operating Expenses slipped to $483.1 million in Q1 2026 per PRGO's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.5 billion in Q4 2025 and bottomed at -$297.2 million in Q4 2024.
- Historically, Other Operating Expenses has averaged $257.6 million across 5 years, with a median of $164.3 million in 2024.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 144.73% — and 2026, when it surged 738.72%.
- Perrigo's Other Operating Expenses stood at $522.9 million in 2022, then rose by 27.06% to $664.4 million in 2023, then sank by 144.73% to -$297.2 million in 2024, then jumped by 604.04% to $1.5 billion in 2025, then slumped by 67.75% to $483.1 million in 2026.
- Business Quant data shows PRGO's Other Operating Expenses at $483.1 million in Q1 2026, $1.5 billion in Q4 2025, and $62.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 46.60 Mn |
| Mar 28, 2026 | 483.10 Mn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 27, 2025 | 62.20 Mn |
| Jun 28, 2025 | 173.80 Mn |
| Mar 29, 2025 | 57.60 Mn |
| Dec 31, 2024 | -297.20 Mn |
| Sep 28, 2024 | 164.30 Mn |
| Jun 29, 2024 | 108.10 Mn |
| Mar 30, 2024 | 87.90 Mn |
| Dec 31, 2023 | 664.40 Mn |
| Sep 30, 2023 | 57.40 Mn |
| Jul 1, 2023 | 199.70 Mn |
| Apr 1, 2023 | 195.80 Mn |
| Dec 31, 2022 | 522.90 Mn |
| Oct 1, 2022 | 60.30 Mn |
| Jul 2, 2022 | 180.20 Mn |
| Apr 2, 2022 | 160.90 Mn |
| Dec 31, 2020 | -122.30 Mn |
| Sep 26, 2020 | 22.20 Mn |